{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:38:59Z","timestamp":1789018739490,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-14-0154"],"award-info":[{"award-number":["APVV-14-0154"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["LQ1605"],"award-info":[{"award-number":["LQ1605"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA 1\/0147\/15"],"award-info":[{"award-number":["VEGA 1\/0147\/15"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopha.2018.01.074","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T11:54:42Z","timestamp":1519127682000},"page":"511-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hypericin affects cancer side populations via competitive inhibition of BCRP"],"prefix":"10.1016","volume":"99","author":[{"given":"Jana","family":"Vargov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarom\u00edr","family":"Mike\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rastislav","family":"Jend\u017eelovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mike\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Kuch\u00e1rov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u013dubom\u00edr","family":"\u010culka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"Fedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1n","family":"Rem\u0161\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Sou\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois","family":"Kozub\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fedoro\u010dko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.biopha.2018.01.074_bib0005","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells--perspectives on current status and future directions: AACR workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.biopha.2018.01.074_bib0015","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.074_bib0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.stem.2011.01.007","article-title":"Critical appraisal of the side population assay in stem cell and cancer stem cell research","volume":"8","author":"Golebiewska","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.biopha.2018.01.074_bib0025","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.074_bib0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V99.2.507","article-title":"The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors","volume":"99","author":"Scharenberg","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2008.04.038","article-title":"Characterization of a stem cell population in lung cancer A549 cells","volume":"371","author":"Sung","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.074_bib0040","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V96.3.902.015k40_902_909","article-title":"Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo","volume":"96","author":"Bunting","year":"2000","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.biopha.2018.01.074_bib0045","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/onc.2013.373","article-title":"Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling","volume":"33","author":"Kim","year":"2014","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.074_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2014.12.005","article-title":"Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species","volume":"137","author":"Mizuno","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.biopha.2018.01.074_bib0055","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-10-0881","article-title":"Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling","volume":"70","author":"Sullivan","year":"2010","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.074_bib0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425255.4.6.697","article-title":"Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily","volume":"4","author":"Marchitti","year":"2008","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2015.08.018","article-title":"Aldehyde dehydrogenases and cancer stem cells","volume":"369","author":"Xu","year":"2015","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.074_bib0070","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1074\/jbc.M607546200","article-title":"Mechanisms involved in the protection of UV-induced protein inactivation by the corneal crystallin ALDH3A1","volume":"282","author":"Estey","year":"2007","journal-title":"J. Biol.Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yexcr.2015.04.018","article-title":"Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment","volume":"335","author":"Islam","year":"2015","journal-title":"Exp.Cell. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2162-3619-2-17","article-title":"CD133: a stem cell biomarker and beyond","volume":"2","author":"Li","year":"2013","journal-title":"Exp. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2018.01.074_bib0085","first-page":"2644","article-title":"Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review","volume":"6","author":"Qu","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.074_bib0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.scr.2016.02.028","article-title":"CD44(high)CD24(low) molecular signature determines the cancer stem cell and EMT phenotype in Oral squamous cell carcinoma","volume":"16","author":"Ghuwalewala","year":"2016","journal-title":"Stem Cell. Res."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.074_bib0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10585-012-9482-4","article-title":"CD44+\/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival","volume":"29","author":"Meng","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.biopha.2018.01.074_bib0100","doi-asserted-by":"crossref","first-page":"708036","DOI":"10.1155\/2012\/708036","article-title":"Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity","volume":"2012","author":"Jaggupilli","year":"2012","journal-title":"Clin. Develop. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.074_bib0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1572-1000(05)00007-4","article-title":"Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization","volume":"1","author":"Castano","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2018.01.074_bib0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.074_bib0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pdpdt.2013.04.003","article-title":"Conjunction of glutathione level, NAD(P)H\/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin","volume":"10","author":"Mike\u0161ov\u00e1","year":"2013","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/104454702753474931","article-title":"An update on photodynamic therapy applications","volume":"20","author":"Dougherty","year":"2002","journal-title":"J. Clin. Laser Med. Surg."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.074_bib0125","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.074_bib0130","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2018.01.074_bib0135","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.seminoncol.2014.09.017","article-title":"Photodynamic therapy for lung cancer and malignant pleural mesothelioma","volume":"41","author":"Simone","year":"2014","journal-title":"Semin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.074_bib0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1357-2725(01)00126-1","article-title":"Hypericin in cancer treatment: more light on the way","volume":"34","author":"Agostinis","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2018.01.074_bib0145","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fpls.2016.00560","article-title":"Hypericin in the light and in the dark: two sides of the Same coin","volume":"7","author":"Jend\u017eelovsk\u00e1","year":"2016","journal-title":"Front. Plant Sci."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.074_bib0150","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ctim.2014.07.007","article-title":"Less like a drug than a drug\u2019: the use of St John\u2019s wort among people who self-identify as having depression and\/or anxiety symptoms","volume":"22","author":"Pirotta","year":"2014","journal-title":"Complement. Ther. Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.074_bib0155","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12248-009-9146-8","article-title":"Herb-drug interactions with St John\u2019s wort (Hypericum perforatum): an update on clinical observations","volume":"11","author":"Borrelli","year":"2009","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.074_bib0160","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ijc.20285","article-title":"Antimetastatic activity of the photodynamic agent hypericin in the dark","volume":"111","author":"Blank","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.074_bib0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1562\/0031-8655(2001)074<0120:ACAOHI>2.0.CO;2","article-title":"Anti-cancer activities of hypericin in the dark","volume":"74","author":"Blank","year":"2001","journal-title":"Photochem.Photobiol."},{"issue":"23","key":"10.1016\/j.biopha.2018.01.074_bib0170","first-page":"8241","article-title":"Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin","volume":"63","author":"Blank","year":"2003","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.074_bib0175","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.bjp.0704399","article-title":"Saint John\u2019s wort: an in vitro analysis of P-glycoprotein induction due to extended exposure","volume":"134","author":"Perloff","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2018.01.074_bib0180","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1039\/b9pp00086k","article-title":"Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells","volume":"8","author":"Jend\u017eelovsk\u00fd","year":"2009","journal-title":"Photochem. Photobiol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.074_bib0185","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.tiv.2014.06.011","article-title":"Single pre-treatment with hypericin, a St. John\u2019s wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells","volume":"28","author":"Jend\u017eelovsk\u00e1","year":"2014","journal-title":"Toxicol. Vitro: Int. J. Pub. Assoc. BIBRA."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.074_bib0190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.pdpdt.2015.04.008","article-title":"Potentiation of hypericin-mediated photodynamic therapy cytotoxicity by MK-886: focus on ABC transporters, GDF-15 and redox status","volume":"12","author":"Kuch\u00e1rov\u00e1","year":"2015","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.074_bib0195","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.65.6.1485","article-title":"High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter","volume":"65","author":"Ozvegy-Laczka","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.01.074_bib0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(96)00237-2","article-title":"Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells","volume":"383","author":"Hollo","year":"1996","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.074_bib0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/104303403321209005","article-title":"Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells","volume":"14","author":"Ujhelly","year":"2003","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.074_bib0210","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cyto.a.22273","article-title":"Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells","volume":"83","author":"Fedr","year":"2013","journal-title":"Cytometry Part A J. Int. Soc. Anal. Cytol."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.074_bib0215","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1039\/b700350a","article-title":"Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin","volume":"6","author":"Mike\u0161","year":"2007","journal-title":"Photochem. Photobiol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.074_bib0220","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/10715762.2011.579120","article-title":"ABC transporters affect the detection of intracellular oxidants by fluorescent probes","volume":"45","author":"Proch\u00e1zkov\u00e1","year":"2011","journal-title":"Free Radic. Res."},{"issue":"10","key":"10.1016\/j.biopha.2018.01.074_bib0225","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","article-title":"Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells","volume":"67","author":"Ho","year":"2007","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.biopha.2018.01.074_bib0230","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.18632\/oncotarget.2053","article-title":"The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics","volume":"5","author":"Boesch","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.074_bib0235","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/or.2015.4057","article-title":"Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin","volume":"34","author":"Yang","year":"2015","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.074_bib0240","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/path.2307","article-title":"Side populations of gastrointestinal cancers are not enriched in stem cells","volume":"214","author":"Burkert","year":"2008","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.074_bib0245","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/stem.582","article-title":"Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme","volume":"29","author":"Broadley","year":"2011","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.biopha.2018.01.074_bib0250","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2018.01.074_bib0255","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1038\/cddis.2012.93","article-title":"Non-small cell lung cancer stem\/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity","volume":"3","author":"Akunuru","year":"2012","journal-title":"Cell. Death Dis."},{"issue":"42","key":"10.1016\/j.biopha.2018.01.074_bib0260","doi-asserted-by":"crossref","first-page":"44191","DOI":"10.18632\/oncotarget.6176","article-title":"Cancer stem cell targeted therapy: progress amid controversies","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2478\/s11658-013-0112-1","article-title":"CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549","volume":"19","author":"Roudi","year":"2014","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.074_bib0270","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neo.2015.01.004","article-title":"ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cells","volume":"17","author":"Liang","year":"2015","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.074_bib0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1753425910365733","article-title":"Three-dimensional spheroid cultures of A549 and HepG2 cells exhibit different lipopolysaccharide (LPS) receptor expression and LPS-induced cytokine response compared with monolayer cultures","volume":"17","author":"Liu","year":"2011","journal-title":"Innate Immun."},{"issue":"12","key":"10.1016\/j.biopha.2018.01.074_bib0280","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-04-0078","article-title":"Phytoestrogens\/flavonoids reverse breast cancer resistance protein\/ABCG2-mediated multidrug resistance","volume":"64","author":"Imai","year":"2004","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2018.01.074_bib0285","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1124\/dmd.113.053140","article-title":"Overlapping substrate and inhibitor specificity of human and murine ABCG2","volume":"41","author":"Bakhsheshian","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.074_bib0290","first-page":"943","article-title":"Differential effect of phenothiazines on MRP1 and P-glycoprotein activity","volume":"23","author":"Wesolowska","year":"2009","journal-title":"In Vivo"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.01.074_bib0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbamem.2005.11.011","article-title":"Phenothiazine maleates stimulate MRP1 transport activity in human erythrocytes","volume":"1720","author":"Wesolowska","year":"2005","journal-title":"Biochim. et Biophys. Acta"},{"issue":"9","key":"10.1016\/j.biopha.2018.01.074_bib0300","doi-asserted-by":"crossref","first-page":"e22849","DOI":"10.1371\/journal.pone.0022849","article-title":"Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy","volume":"6","author":"Barliya","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.074_bib0305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jphotobiol.2010.06.004","article-title":"Comparative in vitro study on the characteristics of different photosensitizers employed in PDT","volume":"100","author":"Berlanda","year":"2010","journal-title":"J. Photochem. Photobiol. B"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.074_bib0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10456-005-3828-3","article-title":"Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications","volume":"8","author":"Lavie","year":"2005","journal-title":"Angiogenesis"},{"issue":"9","key":"10.1016\/j.biopha.2018.01.074_bib0315","first-page":"680","article-title":"Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing","volume":"12","author":"\u010cavarga","year":"2005","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217361012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217361012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:16:52Z","timestamp":1781590612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217361012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":63,"alternative-id":["S0753332217361012"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.074","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypericin affects cancer side populations via competitive inhibition of BCRP","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}